Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by excitingon Jun 04, 2016 4:15pm
113 Views
Post# 24934606

RE:RE:RE:RE:RE:RE:RE:My Theory.....My Opinion..

RE:RE:RE:RE:RE:RE:RE:My Theory.....My Opinion..I do not believe BRP is something put together in a short amount of time. It was probably brewing for almst 3 years since Convalo exist and probably it`s a software for Convalo`needs at the time. It probably turns out recently to be something that can be monetize through LND. I do not think RBP can have for 2016 3 millions contract revenue if it did not prove useful. Maybe 8.5 millions is overpaid (mind you on the actual circumstance it is more 5 millions if we take into account the sp) but in the end if it turn out that RBP can bring in the needed cash flow for LND to grow i don`t see a problem. The dilution is only 12% and not 25% as some joker want you to believe. I am pretty sure RBP will contribute up to 50% of the earning 18 months from now. If my prediction is true LND become a sustainable company and do not need to raise equity forever (that`s the strategy behind this acquisition). Red flag or not the sp is discounted more than it should be. Let the numbers speak for themselve in the quarters to come. It already prove in the last 12 months that all the bashers are wrong. What can you say more on it. 
Bullboard Posts